Technical Analysis for BTX - BioTime, Inc.

Grade Last Price % Change Price Change
grade F 1.08 1.89% 0.02
BTX closed up 1.89 percent on Friday, May 24, 2019, on 36 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical BTX trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
180 Bearish Setup Bearish Swing Setup 1.89%
Lower Bollinger Band Walk Weakness 1.89%
Below Lower BB Weakness 1.89%
Lower Bollinger Band Touch Weakness 1.89%
New Downtrend Bearish -3.57%
Lower Bollinger Band Touch Weakness -3.57%
NR7 Range Contraction -4.42%
Inside Day Range Contraction -4.42%

Older signals for BTX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

BioTime, Inc., a biotechnology company, focuses on regenerative medicine and blood plasma volume expanders. The company primarily focuses on regenerative medicine, which refers to therapies based on human embryonic stem cell and induced pluripotent stem cell technology designed to rebuild cell and tissue function lost due to degenerative disease or injury. It develops and markets research products in the field of stem cells, including an array of proprietary PureStem cell lines and associated ESpan culture media, HyStem hydrogels, and differentiation kits, as well as offers Hextend, a blood plasma volume expander. The company is developing Renevia, a biocompatible, implantable hyaluronan, and collagen-based matrix for cell delivery in human clinical applications; stem cell-based therapies for retinal and neural degenerative diseases; and therapies to treat orthopedic disorders, diseases, and injuries. It is also developing PanC-Dx, a non-invasive blood-based cancer screening test; and therapeutic products for cardiovascular and blood diseases and disorders. In addition, the company markets GeneCards, a human gene database. Further, it is developing an integrated database suite to complement GeneCards that would include the LifeMap database of embryonic development, stem cell research, and regenerative medicine, as well as MalaCards, the human disease database. BioTime, Inc. was founded in 1990 and is headquartered in Alameda, California.
Biotechnology Life Sciences Biology Diseases Stem Cells Emerging Technologies Disorders Therapeutic Products Regenerative Medicine Injury Degenerative Disease Induced Stem Cells Human Disease Injuries Biotime Culture Media Embryonic Stem Cell
Is BTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 2.81
52 Week Low 0.66
Average Volume 693,088
200-Day Moving Average 1.6066
50-Day Moving Average 1.29
20-Day Moving Average 1.1845
10-Day Moving Average 1.128
Average True Range 0.0833
ADX 27.41
+DI 10.1708
-DI 24.4099
Chandelier Exit (Long, 3 ATRs ) 1.0801
Chandelier Exit (Short, 3 ATRs ) 1.2699
Upper Bollinger Band 1.322
Lower Bollinger Band 1.047
Percent B (%b) 0.12
BandWidth 23.216547
MACD Line -0.0488
MACD Signal Line -0.041
MACD Histogram -0.0078
Fundamentals Value
Market Cap 125.07 Million
Num Shares 116 Million
EPS 0.60
Price-to-Earnings (P/E) Ratio 1.80
Price-to-Sales 81.83
Price-to-Book 1.49
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.19
Resistance 3 (R3) 1.18 1.15 1.17
Resistance 2 (R2) 1.15 1.12 1.15 1.16
Resistance 1 (R1) 1.11 1.10 1.13 1.12 1.16
Pivot Point 1.08 1.08 1.09 1.08 1.08
Support 1 (S1) 1.04 1.05 1.06 1.05 1.00
Support 2 (S2) 1.01 1.03 1.01 1.00
Support 3 (S3) 0.97 1.01 0.99
Support 4 (S4) 0.98